Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riadh Gouider

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Neurogenetics|June 28, 2018
Clinical and genetic study of Tunisian families with genetic generalized epilepsy: contribution of CACNA1H and MAST4 genesZied Landoulsi, Fatma Laatar, Eric Noé, et al.
La Tunisie Medicale|March 12, 2024
Psychiatric disturbances in idiopathic epilepsySaloua Mrabet, Syrine Belguith, Imen Kacem, et al.
Journal of Movement Disorders|April 22, 2024
The Impact of LRRK2 G2019S on Parkinson's Disease: Clinical Phenotype and Treatment in Tunisian PatientsGuedi Ali Barreh, Ikram Sghaier, Youssef Abida, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|August 2, 2019
Juvenile myoclonic epilepsy phenotype in a family with Unverricht-Lundborg diseaseAmina Gargouri Berrechid, Mouna Bendjebara, Delphine Bouteiller, et al.
Neurobiology of Aging|July 7, 2015
Novel presenilin 1 mutation (p.I83T) in Tunisian family with early-onset Alzheimer's diseaseAfef Achouri-Rassas, Nadia Ben Ali, Saloua Fray, et al.
Current Medical Research and Opinion|October 3, 2007
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosisDouglas S Goodin, Louis D Biermann, Saeed Bohlega, et al.
Multiple Sclerosis International|March 22, 2021
A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon <i>β</i>-1aMohammed Al Jumah, Suleiman Kojan, Raed Alroughani, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 17, 2020
Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19Imen Kacem, Alya Gharbi, Chahida Harizi, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH|June 5, 2023
Prevalence of Mood Disorders and Associated Factors at the Time of the COVID-19 Pandemic: Potocol for a Community Survey in La Manouba Governorate, TunisiaUta Ouali, Amina Aissa, Salsabil Rjaibi, et al.
Multiple Sclerosis and Related Disorders|August 9, 2024
Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based studyMaya Zeineddine, Amal Al-Hajje, Pascale Salameh, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Neurogenetics|June 28, 2018
Clinical and genetic study of Tunisian families with genetic generalized epilepsy: contribution of CACNA1H and MAST4 genesZied Landoulsi, Fatma Laatar, Eric Noé, et al.
La Tunisie Medicale|March 12, 2024
Psychiatric disturbances in idiopathic epilepsySaloua Mrabet, Syrine Belguith, Imen Kacem, et al.
Journal of Movement Disorders|April 22, 2024
The Impact of LRRK2 G2019S on Parkinson's Disease: Clinical Phenotype and Treatment in Tunisian PatientsGuedi Ali Barreh, Ikram Sghaier, Youssef Abida, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|August 2, 2019
Juvenile myoclonic epilepsy phenotype in a family with Unverricht-Lundborg diseaseAmina Gargouri Berrechid, Mouna Bendjebara, Delphine Bouteiller, et al.
Neurobiology of Aging|July 7, 2015
Novel presenilin 1 mutation (p.I83T) in Tunisian family with early-onset Alzheimer's diseaseAfef Achouri-Rassas, Nadia Ben Ali, Saloua Fray, et al.
Current Medical Research and Opinion|October 3, 2007
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosisDouglas S Goodin, Louis D Biermann, Saeed Bohlega, et al.
Multiple Sclerosis International|March 22, 2021
A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon <i>β</i>-1aMohammed Al Jumah, Suleiman Kojan, Raed Alroughani, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 17, 2020
Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19Imen Kacem, Alya Gharbi, Chahida Harizi, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH|June 5, 2023
Prevalence of Mood Disorders and Associated Factors at the Time of the COVID-19 Pandemic: Potocol for a Community Survey in La Manouba Governorate, TunisiaUta Ouali, Amina Aissa, Salsabil Rjaibi, et al.
Multiple Sclerosis and Related Disorders|August 9, 2024
Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based studyMaya Zeineddine, Amal Al-Hajje, Pascale Salameh, et al.
Pageof 12